Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SERRATUS: Serratus Plane Block Analgesia for Pleural Drainage in ICU
2024-515722-83-00Phase 3Authorised
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ropivacaine in acute pain, pleural effusion and pneumothorax (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Intensity of acute pain during pleural drainage. Planned start Jul 2024; status: authorised.
02
Drugs
ropivacaine
03
Conditions
acute painpleural effusionpneumothorax
Beyond the preview
Go deeper on 2024-515722-83-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515722-83-00.